Webinars

Easy assay development with TSA-based multiplexed immunofluorescence

Resource: Easy assay development with TSA-based multiplexed immunofluorescence
ABOUT:

Multiplex immunofluorescence IHC is a powerful technique to address the increasing research needs in immuno-oncology to better understand the tumor microenvironment.
In this webinar we present a rapid and automated high-plex fluorescent immunostaining procedure, using our microfluidic-based staining device LabSat® Research and TSA staining reagents. The 6-marker protocol could be performed in less than 4 hours and 30 minutes, resulting in high-quality marker detection, efficient removal of antibodies, and remarkable signal uniformity.

AGENDA:
  • Microfluidic technology & staining solutions
  • Automated TSA-based multiplexing: tonsil optimization
  • Easy protocol transfer to a specific cancer type Case study: NSCLC
SPEAKER:

Alexandre Kehren – Application Development Team Leader, Lunaphore